Financial statements Solinea Pharma
Balance sheet of Solinea Pharma
Company age:
Age:
10 y. 3 m. 9 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of SOLINEA PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 652 254,78 | 621 447,31 | 70 043,55 | 69 828,85 | 329 315,40 | 537 434,38 |
| A. Fixed assets | 192 888,86 | 115 221,20 | 62 315,20 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 459 365,92 | 506 226,11 | 7 728,35 | 69 828,85 | 329 315,40 | 537 434,38 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | - | - |
| Total liabilities | 652 254,78 | 621 447,31 | 70 043,55 | 69 828,85 | 329 315,40 | 537 434,38 |
| A. Equity | 420 537,65 | 481 485,25 | -255 203,91 | -190 112,99 | -134 662,18 | -20 359,58 |
| B. Liabilities and provisions for liabilities | 231 717,13 | 139 962,06 | 325 247,46 | 259 941,84 | 463 977,58 | 557 793,96 |
| I. Long-term liabilities | 0,00 | 0,00 | 201 339,84 | 0,00 | - | - |
| II. Short-term liabilities | 231 717,13 | 139 962,06 | 123 907,62 | 259 941,84 | 456 777,58 | 531 643,96 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.